![Hui Tian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hui Tian
Private Equity Investor chez
The Column Group LLC
Profil
Dr. Hui Tian is a Partner at The Column Group LLC.
Dr. Tian was previously employed as a Vice President-Research by NGM Biopharmaceuticals, Inc., a Scientific Director by Amgen, Inc., and a Research Investigator by Tularik, Inc.
He received his doctorate degree from Harvard University and a doctorate degree from The University of Texas Southwestern Medical Center.
Postes actifs de Hui Tian
| Sociétés | Poste | Début |
|---|---|---|
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Private Equity Investor | 01/03/2022 |
Anciens postes connus de Hui Tian
| Sociétés | Poste | Fin |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 31/05/2022 |
| AMGEN INC. | Corporate Officer/Principal | 31/12/2008 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Corporate Officer/Principal | 31/12/2004 |
Formation de Hui Tian
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
